
Evogene Ltd. EVGN
€ 0.68
0.29%
Geschäftsbericht 2025
hinzugefügt 25.04.2026
Evogene Ltd. ROE 2011-2026 | EVGN
ROE Jährlich Evogene Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | -41.09 | -30.08 | -41.26 | -30.04 | -22.44 | -16.59 | -12.52 | -7.12 | -5.23 | 1.35 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.35 | -41.26 | -20.5 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | ||
|
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M | ||
|
AIkido Pharma
AIKI
|
-32.34 | - | 1.93 % | $ 17.4 M | ||
|
Nymox Pharmaceutical Corporation
NYMX
|
2477.67 | - | -19.68 % | $ 18.4 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
-5.9 | $ 0.9 | -2.33 % | $ 6.62 M | ||
|
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
626.29 | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
30.9 | $ 21.96 | -0.68 % | $ 3.64 B | ||
|
RedHill Biopharma Ltd.
RDHL
|
-549.43 | $ 1.02 | -0.49 % | $ 428 M | ||
|
Allakos
ALLK
|
-110.0 | - | - | $ 28.6 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | ||
|
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M | ||
|
AlloVir
ALVR
|
-55.11 | - | 4.14 % | $ 49.1 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-256.9 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | ||
|
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | ||
|
Aligos Therapeutics
ALGS
|
-45.18 | $ 6.4 | 4.4 % | $ 63.3 M | ||
|
Applied Therapeutics
APLT
|
698.49 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
-169.38 | - | -39.0 % | $ 4.57 M | ||
|
Aridis Pharmaceuticals
ARDS
|
125.33 | - | 17.91 % | $ 11.1 M | ||
|
Avenue Therapeutics
ATXI
|
-158.79 | - | -52.27 % | $ 4.45 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
12.44 | $ 21.41 | 1.9 % | $ 1 B | ||
|
Aravive
ARAV
|
-716.17 | - | -13.39 % | $ 1.45 M | ||
|
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - | ||
|
AstraZeneca PLC
AZN
|
20.44 | - | - | $ 96.9 B | ||
|
BioDelivery Sciences International
BDSI
|
45.18 | - | -4.8 % | $ 255 M | ||
|
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
103.22 | - | -2.5 % | $ 5.88 M | ||
|
Kazia Therapeutics Limited
KZIA
|
-132.24 | $ 12.26 | 3.72 % | $ 1.62 B | ||
|
AgeX Therapeutics
AGE
|
51843.24 | - | -10.17 % | $ 12.2 K | ||
|
BioNTech SE
BNTX
|
1.11 | $ 105.46 | -0.09 % | $ 27.2 B | ||
|
BeiGene, Ltd.
BGNE
|
6.58 | - | 0.49 % | $ 251 B | ||
|
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
248.9 | $ 4.08 | 0.25 % | $ 436 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-8.52 | $ 23.26 | 1.75 % | $ 2.96 B | ||
|
Cara Therapeutics
CARA
|
-86.96 | - | -3.03 % | $ 260 M | ||
|
Autolus Therapeutics plc
AUTL
|
-161.42 | $ 1.44 | -5.88 % | $ 383 M | ||
|
Aptose Biosciences
APTO
|
93.75 | - | -45.71 % | $ 1.2 M | ||
|
BioXcel Therapeutics
BTAI
|
73.22 | $ 1.06 | -3.64 % | $ 12.9 M | ||
|
CASI Pharmaceuticals
CASI
|
-43.38 | - | - | $ 35.4 M | ||
|
AVROBIO
AVRO
|
12.83 | - | 1083.1 % | $ 745 M | ||
|
Cabaletta Bio
CABA
|
-149.8 | $ 2.95 | -3.28 % | $ 296 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-175.75 | $ 2.91 | -1.36 % | $ 4.79 M | ||
|
bluebird bio
BLUE
|
-108.93 | - | - | $ 546 M | ||
|
CymaBay Therapeutics
CBAY
|
-36.05 | - | - | $ 3.45 B | ||
|
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B |